Royal Bank of Canada
KRON

Royal Bank of Canada’s Kronos Bio KRON Stock Holding History

Royal Bank of Canada’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-308
Closed – – 7147
2024
Q2 		$0 Buy
308
+198
+180% +$202 ﹤0.01% 7309
2024
Q1 		$0 Sell
110
-101
-48% -$115 ﹤0.01% 7306
2023
Q4 		$0 Sell
211
-6,303
-97% -$6.97K ﹤0.01% 7361
2023
Q3 		$8K Buy
+6,514
New +$10.5K ﹤0.01% 6497
2023
Q2 		– Sell
-2,301
Closed -$3K – 7454
2023
Q1 		$3K Sell
2,301
-3,450
-60% -$6.61K ﹤0.01% 6695
2022
Q4 		$9K Sell
5,751
-5,025
-47% -$11.6K ﹤0.01% 6580
2022
Q3 		$36K Buy
10,776
+266
+3% +$1.2K ﹤0.01% 5903
2022
Q2 		$38K Sell
10,510
-2,156
-17% -$9.77K ﹤0.01% 5840
2022
Q1 		$91K Sell
12,666
-5,107
-29% -$43.5K ﹤0.01% 5722
2021
Q4 		$242K Buy
17,773
+12,236
+221% +$191K ﹤0.01% 5148
2021
Q3 		$116K Buy
5,537
+1,879
+51% +$40.4K ﹤0.01% 5601
2021
Q2 		$88K Buy
3,658
+1,375
+60% +$34.8K ﹤0.01% 5694
2021
Q1 		$67K Buy
2,283
+1,007
+79% +$29.5K ﹤0.01% 5700
2020
Q4 		$38K Buy
+1,276
New +$40K ﹤0.01% 5768

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada's KRON Position: Q3 2024 in Review

Royal Bank of Canada sold out of Kronos Bio (KRON) in Q3 2024, closing a stake of 308 shares.

Royal Bank of Canada first reported a position in KRON in Q4 2020 and held it in 14 quarters. The position peaked at $242K in Q4 2021. 53 funds tracked by Wall St. Rank hold KRON as of Q3 2024.

  • Royal Bank of Canada reported no remaining Kronos Bio position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 308 Kronos Bio shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Kronos Bio in Q4 2020 and held it in 14 quarters.
  • Royal Bank of Canada's Kronos Bio position peaked at $242K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.